A novel target in DNA metabolism for cytotoxic drugs
- PMID: 2837241
- DOI: 10.1016/0006-2952(88)90454-6
A novel target in DNA metabolism for cytotoxic drugs
Similar articles
-
Inhibition of DNA ligase from human thymocytes and normal or leukemic lymphocytes by antileukemic drugs.Cancer Res. 1985 May;45(5):2177-83. Cancer Res. 1985. PMID: 3986768
-
Novobiocin-mediated inhibition of polymerization and ligation of DNA in vitro.Mutat Res. 1984 Oct;141(2):69-73. doi: 10.1016/0165-7992(84)90013-7. Mutat Res. 1984. PMID: 6493269 No abstract available.
-
Studies on the affinity of chick embryo DNA ligase for ribonucleotides and deoxyribonucleotides.FEBS Lett. 1977 Dec 1;84(1):156-8. doi: 10.1016/0014-5793(77)81078-8. FEBS Lett. 1977. PMID: 304018 No abstract available.
-
Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?Biochem Pharmacol. 1991 Nov 27;42(12):2253-8. doi: 10.1016/0006-2952(91)90227-v. Biochem Pharmacol. 1991. PMID: 1662508 Review. No abstract available.
-
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.Biochim Biophys Acta. 1998 Oct 1;1400(1-3):139-54. doi: 10.1016/s0167-4781(98)00132-8. Biochim Biophys Acta. 1998. PMID: 9748545 Review.
Cited by
-
Correlation between anthracycline structure and human DNA ligase inhibition.Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):141-6. doi: 10.1042/bj2790141. Biochem J. 1991. PMID: 1930131 Free PMC article.
-
Widely used catalysts in biodiesel production: a review.RSC Adv. 2020 Nov 13;10(68):41625-41679. doi: 10.1039/d0ra07931f. eCollection 2020 Nov 11. RSC Adv. 2020. PMID: 35516564 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources